Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 May;35(5):1244–1247. doi: 10.1128/jcm.35.5.1244-1247.1997

Seroreactivity to hepatitis E virus in areas where the disease is not endemic.

D L Thomas 1, P O Yarbough 1, D Vlahov 1, S A Tsarev 1, K E Nelson 1, A J Saah 1, R H Purcell 1
PMCID: PMC232737  PMID: 9114415

Abstract

If the occurrence of hepatitis E virus antibody (anti-HEV) in regions where the disease is not endemic represents infection, rates may be greater in high-risk populations and behavioral correlates may reflect recognized transmission modes. Serum samples from 300 homosexual males, 300 injection drug users (IDUs), and 300 blood donors from Baltimore, Md., were tested for anti-HEV by enzyme immunoassay. Anti-HEV was found in an unexpectedly high percentage of homosexual men (15.9%) and IDUs (23.0%). However, anti-HEV was present in a similar proportion of blood donors (21.3%) (P > 0.05), while hepatitis A, B, and C virus antibodies were more prevalent in the high-risk groups (P < 0.001). Among homosexual men, anti-HEV was not significantly correlated with a history of hepatitis, high-risk sexual practices, or sexually transmitted infections, in contrast to hepatitis A and B antibodies. Among IDUs, anti-HEV was not significantly associated with a history of hepatitis or high-risk drug-using practices, as was found with hepatitis C antibodies. In a setting without endemic hepatitis E disease, there was no evidence that anti-HEV reflected subclinical infection. Until the basis for HEV seroreactivity in such areas is elucidated, anti-HEV results should be interpreted with caution.

Full Text

The Full Text of this article is available as a PDF (117.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bryan J. P., Tsarev S. A., Iqbal M., Ticehurst J., Emerson S., Ahmed A., Duncan J., Rafiqui A. R., Malik I. A., Purcell R. H. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis. 1994 Sep;170(3):517–521. doi: 10.1093/infdis/170.3.517. [DOI] [PubMed] [Google Scholar]
  2. Corey L., Holmes K. K. Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. N Engl J Med. 1980 Feb 21;302(8):435–438. doi: 10.1056/NEJM198002213020804. [DOI] [PubMed] [Google Scholar]
  3. Donahue J. G., Nelson K. E., Muñoz A., Vlahov D., Rennie L. L., Taylor E. L., Saah A. J., Cohn S., Odaka N. J., Farzadegan H. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol. 1991 Nov 15;134(10):1206–1211. doi: 10.1093/oxfordjournals.aje.a116023. [DOI] [PubMed] [Google Scholar]
  4. Ghabrah T. M., Stickland G. T., Tsarev S., Yarbough P., Farci P., Engle R., Emerson S., Purcell R. Acute viral hepatitis in Saudi Arabia: seroepidemiological analysis, risk factors, clinical manifestations, and evidence for a sixth hepatitis agent. Clin Infect Dis. 1995 Sep;21(3):621–627. doi: 10.1093/clinids/21.3.621. [DOI] [PubMed] [Google Scholar]
  5. Goldsmith R., Yarbough P. O., Reyes G. R., Fry K. E., Gabor K. A., Kamel M., Zakaria S., Amer S., Gaffar Y. Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet. 1992 Feb 8;339(8789):328–331. doi: 10.1016/0140-6736(92)91647-q. [DOI] [PubMed] [Google Scholar]
  6. Rompalo A. M., Cannon R. O., Quinn T. C., Hook E. W., 3rd Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis. 1992 Jun;165(6):1124–1126. doi: 10.1093/infdis/165.6.1124. [DOI] [PubMed] [Google Scholar]
  7. Scharschmidt B. F. Hepatitis E: a virus in waiting. Lancet. 1995 Aug 26;346(8974):519–520. doi: 10.1016/s0140-6736(95)91376-9. [DOI] [PubMed] [Google Scholar]
  8. Thomas D. L., Mahley R. W., Badur S., Palaoglu K. E., Quinn T. C. Epidemiology of hepatitis E virus infection in Turkey. Lancet. 1993 Jun 19;341(8860):1561–1562. doi: 10.1016/0140-6736(93)90698-g. [DOI] [PubMed] [Google Scholar]
  9. Thomas D. L., Vlahov D., Solomon L., Cohn S., Taylor E., Garfein R., Nelson K. E. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 1995 Jul;74(4):212–220. doi: 10.1097/00005792-199507000-00005. [DOI] [PubMed] [Google Scholar]
  10. Tsarev S. A., Tsareva T. S., Emerson S. U., Govindarajan S., Shapiro M., Gerin J. L., Purcell R. H. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10198–10202. doi: 10.1073/pnas.91.21.10198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tsarev S. A., Tsareva T. S., Emerson S. U., Rippy M. K., Zack P., Shapiro M., Purcell R. H. Experimental hepatitis E in pregnant rhesus monkeys: failure to transmit hepatitis E virus (HEV) to offspring and evidence of naturally acquired antibodies to HEV. J Infect Dis. 1995 Jul;172(1):31–37. doi: 10.1093/infdis/172.1.31. [DOI] [PubMed] [Google Scholar]
  12. Zaaijer H. L., Kok M., Lelie P. N., Timmerman R. J., Chau K., van der Pal H. J. Hepatitis E in The Netherlands: imported and endemic. Lancet. 1993 Mar 27;341(8848):826–826. doi: 10.1016/0140-6736(93)90599-c. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES